Clinical TrialsSearch results
Number of results: 562
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- ATOM study
- Health Condition(s) or Problem(s) Studied Primary colon cancer(cecum or ascending colon)
- Shiomi Akio
- 2023-12-01
Recruiting
- RehaBoost trial
- lung cancer patients with air flow limitation scheduled for surgical treatment
- Ohde Yasuhisa
- 2023-11-30
Recruiting
- Clinical study to evaluate the efficacy of the novel driver pad for magnetic resonance elastography
- This study is aimed at adult volunteers.
- Goshima Satoshi
- 2023-11-21
Recruiting
- Phase 3 Study of ALXN1850 versus Placebo in Adolescent and Adult Participants with HPP who have not previously been treated with Asfotase Alfa
- Hypophosphatasia
- Wuebbenhorst Hiroaki
- 2023-11-19
Recruiting
- Randomized, placebo-controlled trial of efficacy of midazolam for breathlessness
- Cancer
- Mori Masanori
- 2023-11-17
Recruiting
- Study on the interaction between remimazolam and inhaled anesthetics (sevoflurane)
- Patient undergoing general anesthesia and i-gel insertion
- Kobayashi Kensuke
- 2023-11-10
Recruiting
- Does oral administration of rifaximin improve the quality of life of patients with non-alcoholic fatty liver disease with hyperammonemia and covert hepatic encephalopathy?
- Non-alcoholic fatty liver disease (NAFLD)
- Kazuhito Kawata
- 2023-11-07
Recruiting
- A single-center, prospective, randomized trial to evaluate the efficacy of ablation using the spatiotemporally distributed potentials visualized by a fractionation map compared with ablation using low-potential regions visualized by a voltage map in patients with recurrent sustained atrial fibrillation (ARCHERY trial).
- Recurrent Persistent Atrial Fibrillation
- Naruse Yoshihisa
- 2023-11-02
Recruiting
- Effectiveness of Practical Protection Education Using Real-Time Dosimeters for Nurses
- None
- Nakamura Katsumasa
- 2023-09-29
Not yet recruiting
- Retrospective analysis of the risk factors, outcome, antimicrobial cost and susceptibility for bacteremia caused by ESBL-producing enterobacteriaceae
- bacteremia
- Kato Jun
- 2023-09-25